| · Журналы
· Книги
· О проекте
·Электронные версии книг издательства “Атмосфера” поступили в продажу
Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания.
Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru
ИНТЕРНЕТ-МАГАЗИН
|
|
 | |
Атмосфера. Новости кардиологии
2023 / N 1
Актуальные проблемы фармакотерапии у коморбидных больных артериальной гипертонией и хронической обструктивной болезнью легких
Л.Д. Хидирова, Л.А. Шпагина, И.С. Шпагин, А.А. Василенко
References
1. Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, Nair H, Gasevic D, Sridhar D, Campbell H, Chan KY, Sheikh A, Rudan I; Global Health Epidemiology Reference Group (GHERG). Global and regional estimates of COPD prevalence: systematic review and meta-analysis. Journal of Global Health 2015 Dec;5(2):020415.
2. Aisanov Z, Avdeev S, Arkhipov V, Belevskiy A, Chuchalin A, Leshchenko I, Ovcharenko S, Shmelev E, Miravitlles M. Russian guidelines for the management of COPD: algorithm of pharmacologic treatment. International Journal of Chronic Obstructive Pulmonary Disease 2018 Jan;13:183-7.
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine 2006 Nov;3(11):e442.
4. Shpagin IS, Shabalin AV, Shpagina LA, Gerasimenko ON, Shlyakhtina NV. [Features of clinical-functional parameters of the heart, vessels and microcirculation in patients with arterial hypertension in the combination to chronic obstructive pulmonary diseases. Bulletin of Siberian Medicine 2010;9(6):80-6.] (In Russ.)
5. Chuchalin A, Khaltaev N, Antonov N, Galkin D, Manakov L, Antonini P, Murphy M, Solodovnikov AG, Bousquet J, Pereira MH, Demko IV. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. International Journal of Chronic Obstructive Pulmonary Disease 2014 Sep;12:963-74.
6. Grigoryeva NY, Mayorova MV, Kuznetsov AN. [Application of long-acting b2-agonists in the therapy of chronic obstructive pulmonary disease in patients with concomitant ischemic heart disease. Modern Technologies in Medicine 2017;9(1):156-61.] (In Russ.)
7. Zagidullin NS, Zagidullin SZ, Gassanov N. [Antihypertensive therapy in smokers. Arterial Hypertension 2009;15(4):516-23.] (In Russ.)
8. Hahad O, Arnold N, Prochaska JH, Panova-Noeva M, Schulz A, Lackner KJ, Pfeiffer N, Schmidtmann I, Michal M, Beutel M, Wild PS, Keaney JF Jr, Daiber A, Münzel T. Cigarette smoking is related to endothelial dysfunction of resistance, but not conduit arteries in the general population – results from the Gutenberg Health study. Frontiers in Cardiovascular Medicine 2021 May;8:674622.
9. Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Krum H, Hayward CS. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial. Journal of the American College of Cardiology 2010 Apr;55(17):1780-7.
10. Bhatt SP, Dransfield MT. Chronic obstructive pulmonary disease and cardiovascular disease. Translational Research 2013 Oct;162(4):237-51.
11. Khidirova LD, Yakhontov DA, Zenin SA, Kuropii TS. [The impact of chronic obstructive pulmonary disease and hypertension on the development and progression of atrial fibrillation. Cardiovascular Therapy and Prevention 2019;18(5):138-44.] (In Russ.)
12. Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E Jr, She D. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD study. Annals of Epidemiology 2006 Jan;16(1):63-70.
13. Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. International Journal of Chronic Obstructive Pulmonary Disease 2009;4:337-49.
14. Takajo Y, Ikeda H, Haramaki N, Murohara T, Imaizumi T. Augmented oxidative stress of platelets in chronic smokers. Mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet aggregability. Journal of the American College of Cardiology 2001 Nov;38(5):1320-7.
15. Mahmoodi BK, Cushman M, Anne Næss I, Allison MA, Bos WJ, Brækkan SK, Cannegieter SC, Gansevoort RT, Gona PN, Hammerstrøm J, Hansen JB, Heckbert S, Holst AG, Lakoski SG, Lutsey PL, Manson JE, Martin LW, Matsushita K, Meijer K, Overvad K, Prescott E, Puurunen M, Rossouw JE, Sang Y, Severinsen MT, Ten Berg J, Folsom AR, Zakai NA. Association of traditional cardiovascular risk factors with venous thromboembolism: an individual participant data meta-analysis of prospective studies. Circulation 2017 Jan;135(1):7-16.
16. Khidirova LD, Yakhontov DA, Zenin SA, Mamedov MN. [Features of atrial fibrillation in patients with arterial hypertension and extracardial disorders. Rational Pharmacotherapy in Cardiology 2019;15(3):368-73.] (In Russ.)
17. Matera MG, Calzetta L, Rinaldi B, Cazzola M. Treatment of COPD: moving beyond the lungs. Current Opinion in Pharmacology 2012 Jun;12(3):315-22.
18. Kobalava ZhD, Shavarova EK, Chomova IA, Goreva LA, Karapetyan LV. [Fixed combination of amlodipine/indapamide-retard in the treatment of uncontrolled hypertension in subjects over 55 years old. Arterial Hypertension 2018;24(5):586-95.] (In Russ.)
19. Mascitelli L, Pezzetta F. Inhibition of the renin-angiotensin system in patients with COPD and pulmonary hypertension response. Chest 2007 Mar;131(3):938-9.
20. Lai CC, Wang YH, Wang CY, Wang HC, Yu CJ, Chen L. Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 2018 Mar;13:867-74.
21. Ministry of Health of the Russian Federation; Russian Scientific Medical Society of Therapists. [National clinical recommendations. Diagnosis and treatment of patients with chronic obstructive pulmonary disease and arterial hypertension. Moscow, 2017. 76 p.] (In Russ.)
22. Shpagina LA, Kamneva NV, Kudelya LM, Kotova OS, Shpagin IS, Kuznetsova GV, Anikina EV, Gerasimenko DA, Saraskina LE, Surovenko TN, Ponomareva AV. [Diagnostic and prognostic markers of chronic heart failure in patients with occupational chronic obstructive pulmonary disease. Kardiologiia 2020 Aug;60(7):44-52.] (In Russ.)
23. Harrison MT, Short P, Williamson PA, Singanayagam A, Chalmers JD, Schembri S. Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy? Thorax 2014 Jul;69(7):609-15.
24. Pavasini R, Biscaglia S, d’Ascenzo F, Del Franco A, Contoli M, Zaraket F, Guerra F, Ferrari R, Campo G. Antiplatelet treatment reduces all-cause mortality in COPD patients: a systematic review and meta-analysis. COPD 2016 Aug;13(4):509-14.
25. Janić M, Lunder M, Šabovič M. Arterial stiffness and cardiovascular therapy. BioMed Research International 2014;2014:621437.
26. Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O’Brien E, Ostergren J; ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. The Lancet 2005 Sep;366(9489):895-906.
27. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O’Brien E, Ostergren J; ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized controlled trial. The Lancet 2003 Apr;361(9364):1149-58. |
[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ] |
|
|
